The nuclear receptor Nur77 (NR4A1) and Nurr1 (NR4A2) are closely linked to dopamine neurotransmission and mature and function of dopamine neurons, respectively (Kim et al., 2015; Yan J. et al., 2020), suggesting potential targets of treating PD. The gene discussed is NR4A2; the disease is Parkinson disease.